News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
677,405 Results
Type
Article (33331)
Company Profile (175)
Press Release (643877)
Multimedia
Podcasts (50)
Webinars (11)
Section
Business (216113)
Career Advice (806)
Deals (32427)
Drug Delivery (121)
Drug Development (73552)
Employer Resources (59)
FDA (15614)
Job Trends (13314)
News (319515)
Policy (30006)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (2)
Academia (2052)
Accelerated approval (43)
ADA (39)
Adcomms (12)
Allergies (183)
Alliances (46034)
ALS (187)
Alzheimer's disease (1566)
Antibody-drug conjugate (ADC) (448)
Approvals (16363)
Artificial intelligence (600)
ASCO (269)
Autoimmune disease (322)
Automation (52)
Bankruptcy (326)
Best Places to Work (10491)
BIO (57)
Biologics (1)
BIOSECURE Act (15)
Biosimilars (193)
BioSpace Insights (87)
Biotechnology (109)
Bladder cancer (203)
Brain cancer (60)
Breast cancer (750)
Cancer (5672)
Cardiovascular disease (427)
Career advice (713)
Career pathing (25)
CAR-T (287)
CDC (38)
Celiac Disease (3)
Cell therapy (773)
Cervical cancer (53)
Clinical research (65900)
Collaboration (1950)
Commercialization (6)
Company closure (2)
Compensation (1501)
Complete response letters (55)
COVID-19 (2099)
CRISPR (91)
C-suite (1142)
Cystic fibrosis (127)
Data (8179)
Decentralized trials (2)
Denatured (29)
Depression (159)
Dermatology (100)
Diabetes (604)
Diagnostics (6263)
Digital health (56)
Diversity (8)
Diversity, equity & inclusion (17)
Drug discovery (258)
Drug pricing (172)
Drug shortages (35)
Duchenne muscular dystrophy (245)
Earnings (86712)
Editorial (49)
Employer branding (7)
Employer resources (61)
Events (111981)
Executive appointments (1044)
FDA (19709)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (23)
Frontotemporal dementia (28)
Funding (1522)
Gene editing (183)
Generative AI (36)
Gene therapy (544)
GLP-1 (866)
Government (3856)
Grass and pollen (5)
Guidances (406)
Healthcare (17101)
Hematology (158)
HIV (83)
Huntington's disease (45)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (95)
Immunology and inflammation (173)
Immuno-oncology (90)
Indications (220)
Infectious disease (2411)
Inflammatory bowel disease (207)
Inflation Reduction Act (13)
Influenza (125)
Intellectual property (301)
Interviews (91)
IPO (14995)
IRA (42)
Job creations (3220)
Job search strategy (652)
JPM (23)
Kidney cancer (21)
Labor market (65)
Layoffs (280)
Leadership (14)
Legal (7325)
Licensing (9)
Liver cancer (85)
Longevity (27)
Lung cancer (799)
Lymphoma (435)
Machine learning (47)
Management (21)
Manufacturing (1086)
Marketing (11)
MASH (173)
Medical affairs (1)
Medical device (14521)
Medtech (14750)
Mergers & acquisitions (18755)
Metabolic disorders (1377)
mRNA (143)
Multiple sclerosis (176)
NASH (12)
Neurodegenerative disease (357)
Neuropsychiatric disorders (74)
Neuroscience (2958)
NextGen: Class of 2026 (5614)
Non-profit (3444)
Now hiring (48)
Obesity (566)
Opinion (154)
Ovarian cancer (223)
Pain (260)
Pancreatic cancer (305)
Parkinson's disease (329)
Partnered (30)
Patents (589)
Patient recruitment (794)
Peanut (60)
People (56142)
Pharmaceutical (42)
Pharmacy benefit managers (26)
Phase 1 (20464)
Phase 2 (28939)
Phase 3 (21343)
Pipeline (10176)
Policy (222)
Postmarket research (2417)
Preclinical (8291)
Press Release (49)
Prostate cancer (315)
Psychedelics (37)
Radiopharmaceuticals (339)
Rare diseases (938)
Real estate (5185)
Recruiting (27)
Regulatory (24248)
Reports (31)
Research institute (2006)
Resumes & cover letters (102)
Rett syndrome (47)
RNA editing (16)
RSV (75)
Schizophrenia (162)
Series A (243)
Series B (195)
Service/supplier (7)
Sickle cell disease (97)
Special edition (11)
Spinal muscular atrophy (146)
Sponsored (27)
Startups (3168)
Stomach cancer (14)
Supply chain (138)
Tariffs (69)
The Weekly (21)
Vaccines (865)
Venture capital (52)
Weight loss (370)
Women's health (125)
Worklife (6)
Date
Today (31)
Last 7 days (572)
Last 30 days (2148)
Last 365 days (26864)
2026 (17188)
2025 (26796)
2024 (31547)
2023 (36135)
2022 (46750)
2021 (50752)
2020 (49027)
2019 (40447)
2018 (30482)
2017 (28536)
2016 (28026)
2015 (34279)
2014 (29236)
2013 (24920)
2012 (27325)
2011 (27698)
2010 (26640)
Location
Africa (578)
Alabama (92)
Alaska (4)
Arizona (377)
Arkansas (16)
Asia (35702)
Australia (5415)
California (13785)
Canada (3771)
China (1389)
Colorado (623)
Connecticut (604)
Delaware (410)
Europe (69649)
Florida (2129)
Georgia (448)
Hawaii (3)
Idaho (58)
Illinois (1145)
India (94)
Indiana (580)
Iowa (19)
Japan (580)
Kansas (131)
Kentucky (41)
Louisiana (51)
Maine (65)
Maryland (1684)
Massachusetts (9560)
Michigan (388)
Minnesota (798)
Mississippi (7)
Missouri (137)
Montana (28)
Nebraska (26)
Nevada (138)
New Hampshire (84)
New Jersey (3634)
New Mexico (20)
New York (3522)
North Carolina (1770)
North Dakota (9)
Northern California (6922)
Ohio (394)
Oklahoma (21)
Oregon (35)
Pennsylvania (2690)
Puerto Rico (29)
Rhode Island (49)
South America (884)
South Carolina (87)
South Dakota (1)
Southern California (5627)
Tennessee (227)
Texas (2295)
United States (48383)
Utah (419)
Vermont (2)
Virginia (312)
Washington D.C. (72)
Washington State (1110)
West Virginia (4)
Wisconsin (136)
Wyoming (1)
677,405 Results for "liberator medical supply inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Liberate Bio Appoints Steven H. Bernstein, M.D., as Chief Medical Officer to Advance In Vivo Cell Programming Toward the Clinic
July 27, 2026
·
4 min read
Press Releases
Liberate Medical Completes Enrollment of 250-Patient PREVENT Pivotal Trial Evaluating VentFree® Respiratory Muscle Stimulator
March 3, 2026
·
4 min read
Press Releases
Liberate Bio Presents New Preclinical Data Supporting First Clinical Evaluation of In Vivo CAR-M Program LIB820 in Autoimmune Disease
May 13, 2026
·
5 min read
Manufacturing
Amid $55B US manufacturing push, J&J turns to streamlining its pharma supply chain
After committing $55 billion last year to bolster U.S. manufacturing capabilities, Johnson & Johnson is making changes to its pharmaceutical supply chain.
July 15, 2026
·
1 min read
·
Gabrielle Masson
Press Releases
Liberate Bio Secures Myeloid-Optimized CAR Design Licenses to Advance In Vivo CAR-M Programs
March 5, 2026
·
3 min read
Press Releases
FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC.
July 29, 2026
·
6 min read
Press Releases
Kyverna Therapeutics and ElevateBio Enter into Commercial Manufacturing and Supply Agreement for Miv-cel
July 27, 2026
·
6 min read
Government
Drugmakers Ask Trump for Staggered Tariffs as ‘Liberation Day’ Arrives
Trump has repeatedly called April 2 “Liberation Day,” alluding to a more sweeping and aggressive set of tariffs. Leerink Partners analysts said that the risks from Trump’s tariffs on the biopharma industry are “underappreciated.”
April 2, 2025
·
2 min read
·
Tristan Manalac
Manufacturing
USP adds Tamiflu, Trulicity to vulnerable list as upstream analysis reshapes supply concerns
Almost half of the top 100 medicines vulnerable to supply disruptions in the U.S. have at least one key starting material with a single source country, according to a new report from United States Pharmacopeia.
April 13, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Niowave, Inc. and Ratio Therapeutics Sign Supply Agreement for Actinium-225 to Advance Targeted Alpha Therapies
June 17, 2026
·
3 min read
1 of 67,741
Next
